← SynDRA
KANAMYCIN
SynDRA canonical compound SYN0005927 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Mechanism of action | bacterial 30S ribosomal subunit inhibitor |
|---|
| Indication | gram-negative bacterial infections |
|---|
| Disease area | infectious disease |
|---|
All known targets
- GJA1
- GJB2
- Stap-coc pbp2
- fabH
- mphB
Mechanisms of action (all sources)
- bacterial 30S ribosomal subunit inhibitor
- Stap-coc pbp2 BINDER
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- NR1I2
- NPY1R
- MMP9
- MMP1
- MLNR
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LCK
- KCNH2
- HTR6
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH2
- HRH1
- HMGCR
- HDAC6
- NPY2R
- NR3C1
- ADORA1
- OPRD1
- TDP1
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- SLC6A4
- SLC6A3
- SLC6A2
- SLC29A1
- SIGMAR1
- SAMHD1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Aminoglycoside Antibacterial
- Anti-Bacterial Agents
- Anti-Infective Agents
- Enzyme Inhibitors
- Protein Synthesis Inhibitors
ATC classes
- J01G · AMINOGLYCOSIDE ANTIBACTERIALS
- S01A · ANTIINFECTIVES
- A07A · INTESTINAL ANTIINFECTIVES
Cross-references
Synonyms
- KANAMYCIN SULFATE
- KANTREX
- KLEBCIL
- kanamycin monosulfate
- kanamycin a
- kanacin
- kanamycin sulfate
- Kanamycin A sulfate
- Kanamycine
- Kanamicina
- Kanamycins
- Aspidium
- KAN
- Kanamycinum
- Kantrex
- Klebcil
- KANAMYCIN A
- Kanamicina [Italian]
- Kanamycin A tetracation
- Kanamycin Base
- Kanamycin monosulfate
- Kanamycin sulfate
- Kenamycin A
- Liposomal Kanamycin
- KM (the Antibiotic)
- Kanamycin [INN:BAN]
- Kanamycin monosulfate (JP15)
- Kanamycinsulfate (JP15)
- Kanamycin sulfate (TN)
- Kanamycin sulfate (USP)
- Kanamycine [INN-French]
- Kanamycinum [INN-Latin]
- Kantrex (TN)
- Kantrex (1:1 sulfate)
- Klebcil (1:1 sulfate)
- RUC37XUP2P
- Kanamycin Complex
Look up KANAMYCIN in the interactive SynDRA portal →